|
Minimization, Omission of Risk Info Increasingly Found in Drug Promos
Drug and medical device companies increasingly are minimizing or omitting the risks associated with their products in advertising and promotional materials, an FDA official says.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives